Literature DB >> 30796080

Fulminant thymomatous AMPAR-antibody limbic encephalitis with hypertonic coma, bruxism, an isoelectric electroencephalogram and temporal cortical atrophy, with recovery.

Nicolás Urriola1, Kavie Soosapilla2, James Drummond3, Mark Thieben1.   

Abstract

Autoimmune encephalitides are a potentially devastating group of treatable disorders with a wide variety of clinical presentations. The most studied autoimmune encephalitis is caused by antibodies to the N-methyl-D-aspartate glutamate receptor. A rarer cause is due to antibodies against the evolutionarily related α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR). The full assortment of electroencephalogram (EEG) and clinical descriptions of the latter are yet to be fully described. A 44-year-old woman with impaired consciousness and subsequent coma characterised by an isoelectric EEG was diagnosed with AMPAR-antibody limbic encephalitis. MRI revealed temporal T2 hyperintensities that improved with immunosuppression, although leaving marked cortical atrophy. Gradual clinical improvement saw the development of aggressive bruxism requiring botulinum toxin injection with eventual meaningful clinical recovery. This case expands the clinical spectrum of AMPAR limbic encephalitis to include aggressive bruxism, and highlights that despite poor clinical and EEG findings at the outset, recovery is still possible. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  botulinum toxin; immunology; neuroimaging

Mesh:

Substances:

Year:  2019        PMID: 30796080      PMCID: PMC6388879          DOI: 10.1136/bcr-2018-227893

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Rapid progression and brain atrophy in anti-AMPA receptor encephalitis.

Authors:  Yi-Chia Wei; Chi-Hung Liu; Jainn-Jim Lin; Kun-Ju Lin; Ko-Lun Huang; Tsong-Hai Lee; Yeu-Jhy Chang; Tsung-I Peng; Kuang-Lin Lin; Ting-Yu Chang; Chien-Hung Chang; Hung-Chou Kuo; Kuo-Hsuan Chang; Mei-Yun Cheng; Chin-Chang Huang
Journal:  J Neuroimmunol       Date:  2013-06-21       Impact factor: 3.478

2.  Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.

Authors:  Romana Höftberger; Agnes van Sonderen; Frank Leypoldt; David Houghton; Michael Geschwind; Jeffrey Gelfand; Mercedes Paredes; Lidia Sabater; Albert Saiz; Maarten J Titulaer; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2015-05-15       Impact factor: 9.910

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

Review 5.  Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.

Authors:  Bastien Joubert; Philippe Kerschen; Anastasia Zekeridou; Virginie Desestret; Véronique Rogemond; Marie-Océane Chaffois; François Ducray; Vincent Larrue; Benoit Daubail; Ahmed Idbaih; Dimitri Psimaras; Jean-Christophe Antoine; Jean-Yves Delattre; Jérôme Honnorat
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

6.  Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies.

Authors:  Shuangshuang Yang; Jie Qin; Jinghong Li; Yuan Gao; Lu Zhao; Jun Wu; Bo Song; Yuming Xu; Shilei Sun
Journal:  Neurol Sci       Date:  2016-07-27       Impact factor: 3.307

7.  AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

Authors:  Meizan Lai; Ethan G Hughes; Xiaoyu Peng; Lei Zhou; Amy J Gleichman; Huidy Shu; Sabrina Matà; Daniel Kremens; Roberta Vitaliani; Michael D Geschwind; Luis Bataller; Robert G Kalb; Rebecca Davis; Francesc Graus; David R Lynch; Rita Balice-Gordon; Josep Dalmau
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis.

Authors:  Amy J Gleichman; Jessica A Panzer; Bailey H Baumann; Josep Dalmau; David R Lynch
Journal:  Ann Clin Transl Neurol       Date:  2014-03-01       Impact factor: 4.511

  8 in total
  2 in total

Review 1.  Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review.

Authors:  Tian-Yi Zhang; Meng-Ting Cai; Yang Zheng; Qi-Lun Lai; Chun-Hong Shen; Song Qiao; Yin-Xi Zhang
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

2.  A case of anti-VGKC antibody encephalitis and prolonged encephalopathy despite spontaneous resolution of imaging abnormalities.

Authors:  Victoria Novoselova; Vikas Kumar; Niranjan N Singh; Alexandre Lacasse
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.